OrganiGram Holdings Inc (OGI) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.017x

Based on the latest financial reports, OrganiGram Holdings Inc (OGI) has a cash flow conversion efficiency ratio of -0.017x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-6.30 Million ≈ $-4.56 Million USD) by net assets (CA$371.81 Million ≈ $268.96 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can OrganiGram Holdings Inc fund operations to measure how many days the company can operate on defensive assets alone.

OrganiGram Holdings Inc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how OrganiGram Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

OrganiGram Holdings Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of OrganiGram Holdings Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Limes Schlosskliniken AG
XETRA:LIK
0.135x
Leapfrog Acquisition Corporation Class A Ordinary Shares
NASDAQ:LFAC
-0.003x
Namyong Terminal PCL
BK:NYT
0.085x
Fiamma Holdings Bhd
KLSE:6939
-0.012x
ATEME SA
PA:ATEME
0.030x
Western Forest Products Inc
TO:WEF
0.000x
ROKISKIO SURIS PC EO 029
F:YTV
N/A
Mahamaya Steel Industries Limited
NSE:MAHASTEEL
-0.024x

Annual Cash Flow Conversion Efficiency for OrganiGram Holdings Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of OrganiGram Holdings Inc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see OGI market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-09-30 CA$349.13 Million
≈ $252.56 Million
CA$-5.99 Million
≈ $-4.33 Million
-0.017x -235.58%
2024-09-30 CA$305.99 Million
≈ $221.35 Million
CA$3.87 Million
≈ $2.80 Million
0.013x +109.60%
2023-09-30 CA$271.62 Million
≈ $196.49 Million
CA$-35.80 Million
≈ $-25.89 Million
-0.132x -84.90%
2022-09-30 CA$508.06 Million
≈ $367.52 Million
CA$-36.21 Million
≈ $-26.19 Million
-0.071x -19.62%
2021-09-30 CA$479.81 Million
≈ $347.08 Million
CA$-28.59 Million
≈ $-20.68 Million
-0.060x +60.45%
2020-09-30 CA$299.53 Million
≈ $216.67 Million
CA$-45.12 Million
≈ $-32.64 Million
-0.151x -40.43%
2019-09-30 CA$327.01 Million
≈ $236.55 Million
CA$-35.08 Million
≈ $-25.38 Million
-0.107x -55.88%
2018-09-30 CA$184.59 Million
≈ $133.53 Million
CA$-12.70 Million
≈ $-9.19 Million
-0.069x +6.49%
2017-09-30 CA$83.03 Million
≈ $60.06 Million
CA$-6.11 Million
≈ $-4.42 Million
-0.074x -83.82%
2016-09-30 CA$44.26 Million
≈ $32.02 Million
CA$-1.77 Million
≈ $-1.28 Million
-0.040x +88.66%
2015-09-30 CA$7.85 Million
≈ $5.68 Million
CA$-2.77 Million
≈ $-2.01 Million
-0.353x -193.80%
2014-09-30 CA$24.50K
≈ $17.72K
CA$9.22K
≈ $6.67K
0.376x +157.42%
2013-09-30 CA$263.80K
≈ $190.83K
CA$-172.89K
≈ $-125.06K
-0.655x -93.07%
2012-09-30 CA$461.87K
≈ $334.11K
CA$-156.78K
≈ $-113.41K
-0.339x --

About OrganiGram Holdings Inc

TO:OGI Canada Drug Manufacturers - Specialty & Generic
Market Cap
$143.59 Million
CA$198.49 Million CAD
Market Cap Rank
#17894 Global
#576 in Canada
Share Price
CA$1.41
Change (1 day)
-1.40%
52-Week Range
CA$1.41 - CA$2.90
All Time High
CA$42.88
About

Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Ediso… Read more